CIM
LLY icon

Chiron Investment Management’s Eli Lilly LLY Stock Holding History

Chiron Investment Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-664
Closed -$311K – 110
2023
Q2 		$311K Buy
+664
New +$278K 0.09% 87
2022
Q4 		– Sell
-28,420
Closed -$9.19M – 157
2022
Q3 		$9.19M Buy
+28,420
New +$9M 1.85% 24
2021
Q3 		– Sell
-6,750
Closed -$1.55M – 117
2021
Q2 		$1.55M Buy
+6,750
New +$1.36M 0.19% 41

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Chiron Investment Management's LLY Position: Q3 2023 in Review

Chiron Investment Management sold out of Eli Lilly (LLY) in Q3 2023, closing a stake of 664 shares — an estimated $311K sold.

Chiron Investment Management first reported a position in LLY in Q2 2021 and held it in 3 quarters. The position peaked at $9.19M in Q3 2022. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • Chiron Investment Management reported no remaining Eli Lilly position as of Q3 2023 after selling out during the quarter.
  • Chiron Investment Management sold 664 Eli Lilly shares in Q3 2023, an estimated $311K.
  • Chiron Investment Management first reported a position in Eli Lilly in Q2 2021 and held it in 3 quarters.
  • Chiron Investment Management's Eli Lilly position peaked at $9.19M in Q3 2022.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on Chiron Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.